Skip to main content

Infection in Immunocompromised Pediatric Patients

The Infection in Immunocompromised Pediatric Patients research group is a multidisciplinary pediatric research group made up of health professionals involved in translational research in the field of pediatric infectious diseases and immunodeficiencies, two related fields in terms of pathophysiology and clinical implications. It is a consolidated research group recognized by the AGAUR and is the only one with the accreditation of the Jeffrey Modell Foundation in research in the field of primary immunodeficiencies throughout the state.

The group was officially created in 2010, belongs to the area of Infectious Diseases and participates in the transversal programs of Advanced Translational Immunology and Rare Diseases and actively participates in national and international competitive projects, carries out multiple academic and industry-linked clinical trials and has increased the number and quality in recent years. In addition, it has its own laboratory specially dedicated to advanced immune studies.

Team

Pere Soler Palacín

Pere Soler Palacín

Head of group
Infection in Immunocompromised Pediatric Patients
Read more
Andrea Martín Nalda

Andrea Martín Nalda

Infection in Immunocompromised Pediatric Patients
Read more
Antoni Soriano Arandes

Antoni Soriano Arandes

Infection in Immunocompromised Pediatric Patients
Read more
Jacques Gabriel Rivière

Jacques Gabriel Rivière

Predoctoral researcher
Infection in Immunocompromised Pediatric Patients
Read more
Jorgina Vila Soler

Jorgina Vila Soler

Predoctoral researcher
Infection in Immunocompromised Pediatric Patients
Read more
Maria Espiau Guarner

Maria Espiau Guarner

Infection in Immunocompromised Pediatric Patients
Read more
Pere Soler Palacín

Pere Soler Palacín

Head of group
Infection in Immunocompromised Pediatric Patients
Read more
Andrea Martín Nalda

Andrea Martín Nalda

Infection in Immunocompromised Pediatric Patients
Read more
Antoni Soriano Arandes

Antoni Soriano Arandes

Infection in Immunocompromised Pediatric Patients
Read more
Jacques Gabriel Rivière

Jacques Gabriel Rivière

Predoctoral researcher
Infection in Immunocompromised Pediatric Patients
Read more
Jorgina Vila Soler

Jorgina Vila Soler

Predoctoral researcher
Infection in Immunocompromised Pediatric Patients
Read more
Maria Espiau Guarner

Maria Espiau Guarner

Infection in Immunocompromised Pediatric Patients
Read more

Research lines

Assessment of pharmacokinetic properties of antimicrobials in children [Infectious diseases]

IP: Pere Soler Palacín

Better definition and treatment of combined IEI [Innate errors of immunity (IEI)]

IP: Andrea Martín Nalda, Pere Soler Palacín

Optimization of diagnosis and treatment of tuberculosis, imported diseases ans sexually transmitted diseases [Infectious diseases]

IP: Antoni Soriano Arandes, Maria Espiau Guarner

Optimization of therapeutic approaches in pediatric patients with IEI [Innate errors of immunity (IEI)]

IP: Jacques Gabriel Rivière , Pere Soler Palacín

Projects

RECOMB: Stem-cell based gene therapy for recombination deficient SCID

IP: Pere Soler Palacín
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 57500
Reference: RECOMB_H2020SCI2017
Duration: 01/01/2018 - 31/12/2022

Health information and technology for improved Health education in South-East Asia (HITIHE)

IP: Antoni Soriano Arandes
Collaborators: Maria Espiau Guarner
Funding agency: EUROPEAN COMMISSION
Funding: 24200
Reference: HITIHE ERASMUS+EAC/A03_2018
Duration: 15/11/2019 - 14/11/2022

Estudio fase IV, aleatorizado, abierto, controlado para evaluar la terminación temprana del tratamiento con antibioticos en pacientes oncohematológicos con neutropenia febril (e-STOP

IP: Pere Soler Palacín
Collaborators: Luís Gros Subias, Juliana Esperalba Esquerra, Natalia Ana Mendoza Palomar, Núria Worner Tomasa, Berta Sofia Fernandez Ledesma, Susana Melendo Perez
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI19/01522
Duration: 01/01/2020 - 31/12/2022

SARS-CoV-2 and other respiratory viruses in childhood: different approaches to define predictive models for their diagnosis and epidemiological evolution

IP: Antoni Soriano Arandes
Collaborators: Jorgina Vila Soler, Joan Balcells Ramirez, Núria Worner Tomasa, Clara Franco Jarava, Cristina Andrés Vargés
Funding agency: Fundació La Marató de TV3
Funding: 161075
Reference: 202134
Duration: 23/09/2021 - 22/09/2024

FPII per Investigación de Patologia Infecciosa en el Pacient Pediàtric Inmunodeprimit

IP: Pere Soler Palacín
Collaborators: Alba Parra Martínez, Laia Perez Lasarte
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 35800
Reference: PEJ2018-004727-A
Duration: 01/11/2019 - 31/10/2021

ZIKAction: Preparedness, research and action network on maternal-paediatric axis of ZIKV infection in Latin America and the Caribbean

IP: -
Collaborators: Antoni Soriano Arandes, Aroa Silgado Gimenez, Elena Sulleiro Igual, Antoni Soriano Arandes
Funding agency: EUROPEAN COMMISSION
Funding: 302446.75
Reference: ZIKACTION_H2020SC1-2016
Duration: 01/10/2016 - 30/09/2021

RECOMB: Stem-cell based gene therapy for recombination deficient SCID

IP: Pere Soler Palacín
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 57500
Reference: RECOMB_H2020SCI2017
Duration: 01/01/2018 - 31/12/2022

Health information and technology for improved Health education in South-East Asia (HITIHE)

IP: Antoni Soriano Arandes
Collaborators: Maria Espiau Guarner
Funding agency: EUROPEAN COMMISSION
Funding: 24200
Reference: HITIHE ERASMUS+EAC/A03_2018
Duration: 15/11/2019 - 14/11/2022

Sol·licitud beques Predoctoral. Modalitat VHIR-MIR

IP: Pere Soler Palacín
Collaborators: Natalia Ana Mendoza Palomar, Laia Perez Lasarte
Funding agency: Fundació Institut de Recerca HUVH
Funding: 46800
Reference: PRED-VHIR-16-34/MENDOZA
Duration: 01/03/2017 - 29/02/2020

FPII per Investigación de Patologia Infecciosa en el Pacient Pediàtric Inmunodeprimit

IP: Pere Soler Palacín
Collaborators: Alba Parra Martínez, Laia Perez Lasarte
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 35800
Reference: PEJ2018-004727-A
Duration: 01/11/2019 - 31/10/2021

Fungal Biomarker for Diagnosis and Response to Therapy for Pediatric Candidemia

IP: Pere Soler Palacín
Collaborators: -
Funding agency: National Institutes of Health (NIH)
Funding: 27203.94
Reference: BIOPIC_NIH2015
Duration: 03/09/2015 - 31/05/2020

ZIKAction: Preparedness, research and action network on maternal-paediatric axis of ZIKV infection in Latin America and the Caribbean

IP: -
Collaborators: Antoni Soriano Arandes, Aroa Silgado Gimenez, Elena Sulleiro Igual, Antoni Soriano Arandes
Funding agency: EUROPEAN COMMISSION
Funding: 302446.75
Reference: ZIKACTION_H2020SC1-2016
Duration: 01/10/2016 - 30/09/2021

Sol·licitud beques Predoctoral. Modalitat VHIR-MIR

IP: Pere Soler Palacín
Collaborators: Natalia Ana Mendoza Palomar, Laia Perez Lasarte
Funding agency: Fundació Institut de Recerca HUVH
Funding: 46800
Reference: PRED-VHIR-16-34/MENDOZA
Duration: 01/03/2017 - 29/02/2020

FPII per Investigación de Patologia Infecciosa en el Pacient Pediàtric Inmunodeprimit

IP: Pere Soler Palacín
Collaborators: Alba Parra Martínez, Laia Perez Lasarte
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 35800
Reference: PEJ2018-004727-A
Duration: 01/11/2019 - 31/10/2021

Fungal Biomarker for Diagnosis and Response to Therapy for Pediatric Candidemia

IP: Pere Soler Palacín
Collaborators: -
Funding agency: National Institutes of Health (NIH)
Funding: 27203.94
Reference: BIOPIC_NIH2015
Duration: 03/09/2015 - 31/05/2020

Estudio observacional de la infección tuberculosa y utilidad del QUANTIFERON-TB GOLD-IN-TUBE ® en los niños que viajan a países con alta incidencia de tuberculosis

IP: Antoni Soriano Arandes
Collaborators: -
Funding agency: SOC.ESPAÑOLA NEUMOLOGIA CIRUGIA TORACICA
Funding: 18000
Reference: SEPAR/PROJ.INVEST/2015/SORIANO
Duration: 01/06/2016 - 31/05/2019

Sol·licitud beques Predoctoral. Modalitat VHIR-MIR

IP: Pere Soler Palacín
Collaborators: Natalia Ana Mendoza Palomar, Laia Perez Lasarte
Funding agency: Fundació Institut de Recerca HUVH
Funding: 46800
Reference: PRED-VHIR-16-34/MENDOZA
Duration: 01/03/2017 - 29/02/2020

Multi-center studies to improve diagnosis and treatment of pediatric candidiasis

IP: Pere Soler Palacín
Collaborators: -
Funding agency: National Institutes of Health (NIH)
Funding: 20000
Reference: PEACE_NIH-NIAID2013
Duration: 01/06/2015 - 31/05/2018

Fungal Biomarker for Diagnosis and Response to Therapy for Pediatric Candidemia

IP: Pere Soler Palacín
Collaborators: -
Funding agency: National Institutes of Health (NIH)
Funding: 27203.94
Reference: BIOPIC_NIH2015
Duration: 03/09/2015 - 31/05/2020

Estudio observacional de la infección tuberculosa y utilidad del QUANTIFERON-TB GOLD-IN-TUBE ® en los niños que viajan a países con alta incidencia de tuberculosis

IP: Antoni Soriano Arandes
Collaborators: -
Funding agency: SOC.ESPAÑOLA NEUMOLOGIA CIRUGIA TORACICA
Funding: 18000
Reference: SEPAR/PROJ.INVEST/2015/SORIANO
Duration: 01/06/2016 - 31/05/2019

Sol·licitud beques Predoctoral. Modalitat VHIR-MIR

IP: Pere Soler Palacín
Collaborators: Natalia Ana Mendoza Palomar, Laia Perez Lasarte
Funding agency: Fundació Institut de Recerca HUVH
Funding: 46800
Reference: PRED-VHIR-16-34/MENDOZA
Duration: 01/03/2017 - 29/02/2020

Penetración de los antibióticos en la infección ósea en el esqueleto inmaduro. Estudio farmacocinético en el modelo animal

IP: Pere Soler Palacín
Collaborators: Juan A. Porcel Vázquez, Aurora Fernandez Polo, Mayli Lung Suarez
Funding agency: Instituto de Salud Carlos III
Funding: 58685
Reference: PI13/00877
Duration: 01/01/2014 - 30/09/2017

Multi-center studies to improve diagnosis and treatment of pediatric candidiasis

IP: Pere Soler Palacín
Collaborators: -
Funding agency: National Institutes of Health (NIH)
Funding: 20000
Reference: PEACE_NIH-NIAID2013
Duration: 01/06/2015 - 31/05/2018

Registration of patients in ESID database

IP: Pere Soler Palacín
Collaborators: -
Funding agency: European Society for Immunodeficiencies
Funding:
Reference: ESIDDB_ESID2013 DUPLICAT CONVENI 2014.019
Duration: 01/01/2015 - 31/12/2017

Penetración de los antibióticos en la infección ósea en el esqueleto inmaduro. Estudio farmacocinético en el modelo animal

IP: Pere Soler Palacín
Collaborators: Juan A. Porcel Vázquez, Aurora Fernandez Polo, Mayli Lung Suarez
Funding agency: Instituto de Salud Carlos III
Funding: 58685
Reference: PI13/00877
Duration: 01/01/2014 - 30/09/2017

Multi-center studies to improve diagnosis and treatment of pediatric candidiasis

IP: Pere Soler Palacín
Collaborators: -
Funding agency: National Institutes of Health (NIH)
Funding: 20000
Reference: PEACE_NIH-NIAID2013
Duration: 01/06/2015 - 31/05/2018

Registration of patients in ESID database

IP: Pere Soler Palacín
Collaborators: -
Funding agency: European Society for Immunodeficiencies
Funding:
Reference: ESIDDB_ESID2013 DUPLICAT CONVENI 2014.019
Duration: 01/01/2015 - 31/12/2017

Fungal Biomarker for Diagnosis and Response to Therapy for Pediatric Candidemia

IP: Pere Soler Palacín
Collaborators: -
Funding agency: National Institutes of Health (NIH)
Funding: 27203.94
Reference: BIOPIC_NIH2015
Duration: 03/09/2015 - 31/05/2020

Penetración de los antibióticos en la infección ósea en el esqueleto inmaduro. Estudio farmacocinético en el modelo animal

IP: Pere Soler Palacín
Collaborators: Juan A. Porcel Vázquez, Aurora Fernandez Polo, Mayli Lung Suarez
Funding agency: Instituto de Salud Carlos III
Funding: 58685
Reference: PI13/00877
Duration: 01/01/2014 - 30/09/2017

Multi-center studies to improve diagnosis and treatment of pediatric candidiasis

IP: Pere Soler Palacín
Collaborators: -
Funding agency: National Institutes of Health (NIH)
Funding: 20000
Reference: PEACE_NIH-NIAID2013
Duration: 01/06/2015 - 31/05/2018

Registration of patients in ESID database

IP: Pere Soler Palacín
Collaborators: -
Funding agency: European Society for Immunodeficiencies
Funding:
Reference: ESIDDB_ESID2013 DUPLICAT CONVENI 2014.019
Duration: 01/01/2015 - 31/12/2017

Penetración ósea de los antibióticos en la infección ósea en el esqueleto inmaduro. Estudio farmacocinético en el modelo animal

IP: Pere Soler Palacín
Collaborators: -
Funding agency: Fundación SEIP
Funding: 6000
Reference: SEIP-2013-01
Duration: 14/03/2014 - 13/03/2015

Penetración de los antibióticos en la infección ósea en el esqueleto inmaduro. Estudio farmacocinético en el modelo animal

IP: Pere Soler Palacín
Collaborators: Juan A. Porcel Vázquez, Aurora Fernandez Polo, Mayli Lung Suarez
Funding agency: Instituto de Salud Carlos III
Funding: 58685
Reference: PI13/00877
Duration: 01/01/2014 - 30/09/2017

Penetración ósea de los antibióticos en la infección ósea en el esqueleto inmaduro. Estudio farmacocinético en el modelo animal

IP: Pere Soler Palacín
Collaborators: -
Funding agency: Fundación SEIP
Funding: 6000
Reference: SEIP-2013-01
Duration: 14/03/2014 - 13/03/2015

Intravenous and subcutaneous immunoglobulin replacemente: a two-way road. Optimizing healthcare quality in patients with primary immunodeficiencies

IP: Pere Soler Palacín
Collaborators: -
Funding agency: CSL Behring, S.A.
Funding: 4152
Reference: CSL-IGMAPS-2012
Duration: 27/09/2012 - 26/09/2013

Síndrome metabólico en niños y adolescentes que viven con el VIH: riesgo de enfermedad cardiovascular en la edad adulta. Estudio en una cohorte nacional de pacientes VIH pediátricos (CoRISpe). Análisis de factores de riesgo relacionados con la resistenci

IP: Maria Espiau Guarner
Collaborators: -
Funding agency: Fundación Sdad.Española Endocrino.Pediatrica
Funding: 6010
Reference: FSEEP-2013-01
Duration: 01/04/2013 - 30/12/2013

Intravenous and subcutaneous immunoglobulin replacemente: a two-way road. Optimizing healthcare quality in patients with primary immunodeficiencies

IP: Pere Soler Palacín
Collaborators: -
Funding agency: CSL Behring, S.A.
Funding: 4152
Reference: CSL-IGMAPS-2012
Duration: 27/09/2012 - 26/09/2013

VOR-IIG-49: Invasive fungal infection in children: clinical presentation, management with Voriconazole and therapeutic drug monitoring.

IP: -
Collaborators: -
Funding agency: Pfizer SA ###
Funding: 42000
Reference: PFIZER_01-2008
Duration: 01/10/2008 - 31/10/2010

VOR-IIG-49: Invasive fungal infection in children: clinical presentation, management with Voriconazole and therapeutic drug monitoring.

IP: -
Collaborators: -
Funding agency: Pfizer SA ###
Funding: 42000
Reference: PFIZER_01-2008
Duration: 01/10/2008 - 31/10/2010

VOR-IIG-49: Invasive fungal infection in children: clinical presentation, management with Voriconazole and therapeutic drug monitoring.

IP: -
Collaborators: -
Funding agency: Pfizer SA ###
Funding: 42000
Reference: PFIZER_01-2008
Duration: 01/10/2008 - 31/10/2010

Publications

Antimicrobial stewardship programs in pediatrics: A growing reality in our country.

PMID: 35120649
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2022
Reference: Enferm Infecc Microbiol Clin (Engl Ed). 2022 Feb;40(2):51-52. doi: 10.1016/j.eimce.2021.12.007.
Impact factor: 1.731
Publication type: Editorail in international publication
Authors: Fernandez-Polo, Aurora; Soler-Palacin, Pere et al.
DOI: 10.1016/j.eimce.2021.12.007

Antimicrobial defined daily dose in neonatal population.

PMID: 35120651
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2022
Reference: Enferm Infecc Microbiol Clin (Engl Ed). 2022 Feb;40(2):59-65. doi: 10.1016/j.eimce.2021.05.012.
Impact factor: 1.731
Publication type: Paper in international publication
Authors: Villanueva-Bueno, Cristina; Montecatine-Alonso, Elena; Jimenez-Parrilla, Francisco; Fernandez-Llamazares, Cecilia M; Manrique-Rodriguez, Silvia; Zamora-Flores, Elena; Dolz, Elisenda; Fernandez-Polo, Aurora; Catillo-Salinas, Felix; Comunas, Juanjo et al.
DOI: 10.1016/j.eimce.2021.05.012

Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.

PMID: 35134165
Journal: CLINICAL INFECTIOUS DISEASES
Year: 2022
Reference: Clin Infect Dis. 2022 Jan 20. pii: 6520762. doi: 10.1093/cid/ciab928.
Impact factor: 9.079
Publication type: Paper in international publication
Authors: Shaheen, Shareef; Hayden, Randall; Suganda, Sri; Zaoutis, Theoklis E; Chang, Yeh-Chung; Yin, Dwight E; Huppler, Anna R; Danziger-Isakov, Lara; Muller, William J; Roilides, Emmanuel et al.
DOI: 10.1093/cid/ciab928

Whole-genome sequencing reveals host factors underlying critical COVID-19.

PMID: 35255492
Journal: NATURE
Year: 2022
Reference: Nature. 2022 Jul;607(7917):97-103. doi: 10.1038/s41586-022-04576-6. Epub 2022 Mar 7.
Impact factor: 49.962
Publication type: Paper in international publication
Authors: Tsinaslanidis, George; Birkinshaw, Isobel; Carter, Joseph; Howard, Kate; Ingham, Joanne; Joy, Rosie; Pearson, Harriet; Roche, Samantha; Scott, Zoe; Bancroft, Hollie et al.
DOI: 10.1038/s41586-022-04576-6

Severe imported Plasmodium falciparum malaria in children: Characteristics and useful factors in the risk stratification.

PMID: 34748988
Journal: Travel Medicine and Infectious Disease
Year: 2021
Reference: Travel Med Infect Dis. 2021 Nov-Dec;44:102196. doi: 10.1016/j.tmaid.2021.102196. Epub 2021 Nov 5.
Impact factor: 6.211
Publication type: Paper in international publication
Authors: Comelli, Agnese, Guarner, Maria Espiau, Tomasoni, Lina Rachele, Zamboni, Agnese Fanetti, Pavon, Belen Moreno, Zanotti, Paola, Caligaris, Silvio, Matteelli, Alberto, Soriano-Arandes, Antoni, Castelli, Francesco et al.
DOI: 10.1016/j.tmaid.2021.102196

Influenza-Associated Disseminated Aspergillosis in a 9-Year-Old Girl Requiring ECMO Support.

PMID: 34575764
Journal: Journal of Fungi
Year: 2021
Reference: J Fungi (Basel). 2021 Sep 5;7(9). pii: jof7090726. doi: 10.3390/jof7090726.
Impact factor: 5.816
Publication type: Letter or abstract
Authors: Velasco-Nuno, Monica, Mendoza-Palomar, Natalia, Melendo-Perez, Susana, Balcells, Joan, Izquierdo-Blasco, Jaume, Martin-Gomez, Maria Teresa, Soler-Palacin, Pere, Riviere, Jacques G et al.
DOI: 10.3390/jof7090726

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.

PMID: 34413139
Journal: Science Immunology
Year: 2021
Reference: Sci Immunol. 2021 Aug 19;6(62). pii: 6/62/eabl4340. doi: 10.1126/sciimmunol.abl4340.
Impact factor: 17.727
Publication type: Paper in international publication
Authors: Bastard, Paul, Gervais, Adrian, Le Voyer, Tom, Rosain, Jeremie, Philippot, Quentin, Manry, Jeremy, Michailidis, Eleftherios, Hoffmann, Hans-Heinrich, Eto, Shohei, Garcia-Prat, Marina et al.
DOI: 10.1126/sciimmunol.abl4340

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.

PMID: 34413140
Journal: Science Immunology
Year: 2021
Reference: Sci Immunol. 2021 Aug 19;6(62). pii: 6/62/eabl4348. doi: 10.1126/sciimmunol.abl4348.
Impact factor: 17.727
Publication type: Paper in international publication
Authors: Morelle, Guillaume, Asano, Takaki, Boisson, Bertrand, Onodi, Fanny, Shahrooei, Mohammad, Darazam, Ilad Alavi, Olyaei, Nasrin Alipour, Mansouri, Davood, Hatipoglu, Nevin, Palabiyik, Figen et al.
DOI: 10.1126/sciimmunol.abl4348

Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies.

PMID: 33161963
Journal: Journal of Allergy and Clinical Immunology-In Practice
Year: 2020
Reference: J Allergy Clin Immunol Pract. 2020 Nov - Dec;8(10):3342-3347. doi: 10.1016/j.jaip.2020.05.008.
Impact factor: 7.574
Publication type: Review in international publication
Authors: Cordero, Elisa, Goycochea-Valdivia, Walter, Mendez-Echevarria, Ana, Allende, Luis M, Alsina, Laia, Bravo Garcia-Morato, Maria, Neth, Olaf, Rodriguez-Gallego, Carlos, Santos-Perez, Juan Luis, Rodriguez Pena, Rebeca et al.
DOI: 10.1016/j.jaip.2020.05.008

Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies.

PMID: 33161954
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2020
Reference: Enferm Infecc Microbiol Clin. 2020 Nov;38(9):438-443. doi: 10.1016/j.eimc.2020.07.001.
Impact factor: 1.654
Publication type: Review in national publication
Authors: Aguilera Cros, Clara, Cordero, Elisa, Goycochea-Valdivia, Walter, Mendez-Echevarria, Ana, Allende, Luis M, Alsina, Laia, Bravo Garcia-Morato, Maria, Gil-Herrera, Juana, Gudiol, Carlota, Len-Abad, Oscar et al.
DOI: 10.1016/j.eimc.2020.07.001

Auto-antibodies against type I IFNs in patients with life-threatening COVID-19.

PMID: 32972996
Journal: SCIENCE
Year: 2020
Reference: Science. 2020 Oct 23;370(6515). pii: science.abd4585. doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
Impact factor: 41.845
Publication type: Paper in international publication
Authors: Manry, Jeremy, Shaw, Elana, Haljasmagi, Liis, Peterson, Part, Lorenzo, Lazaro, Bizien, Lucy, Trouillet-Assant, Sophie, Dobbs, Kerry, de Jesus, Adriana Almeida, Belot, Alexandre et al.
DOI: 10.1126/science.abd4585

Adverse Events Associated With New Injectable-Free Multidrug-Resistant Tuberculosis Drug Regimens.

PMID: 32800388
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2020
Reference: Arch Bronconeumol. 2020 Dec;56(12):823-825. doi: 10.1016/j.arbres.2020.07.006. Epub 2020 Aug 13.
Impact factor: 4.957
Publication type: Letter whit IF
Authors: Mendoza-Palomar, Natalia, Soler-Palacin, Pere, Schaaf, H Simon, Soriano-Arandes, Antoni, Melendo-Perez, Susana, Martin-Nalda, Andrea, Lopez-Seguer, Laura, Carreras-Abad, Clara, Espiau, Maria, Martin-Begue, Nieves et al.
DOI: 10.1016/j.arbres.2020.07.006

First Universal Newborn Screening Program for Severe Combined Immunodeficiency in Europe. Two-Years' Experience in Catalonia (Spain).

PMID: 31695692
Journal: Frontiers in Immunology
Year: 2019
Reference: Front Immunol. 2019 Oct 22;10:2406. doi: 10.3389/fimmu.2019.02406. eCollection 2019.
Impact factor: 4.716
Publication type: Paper in international publication
Authors: Argudo-Ramirez, Ana, Martin-Nalda, Andrea, Pajares-Garcia, Sonia, Gonzalez de Aledo-Castillo, Jose M, Martinez-Gallo, Monica, Garcia-Prat, Marina, Colobran, Roger, Riviere, Jacques G, Quintero, Yania, Collado, Tatiana et al.
DOI: 10.3389/fimmu.2019.02406

Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected and Unexpected Findings.

PMID: 31681265
Journal: Frontiers in Immunology
Year: 2019
Reference: Front Immunol. 2019 Oct 1;10:2325. doi: 10.3389/fimmu.2019.02325. eCollection 2019.
Impact factor: 4.716
Publication type: Paper in international publication
Authors: Rudilla, Francesc, Franco-Jarava, Clara, Martinez-Gallo, Monica, Garcia-Prat, Marina, Martin-Nalda, Andrea, Riviere, Jacques, Aguilo-Cucurull, Aina, Mongay, Laura, Vidal, Francisco, Solanich, Xavier et al.
DOI: 10.3389/fimmu.2019.02325

Identification of 22q11.2 deletion syndrome via newborn screening for severe combined immunodeficiency. Two years' experience in Catalonia (Spain).

PMID: 31663686
Journal: Molecular Genetics & Genomic Medicine
Year: 2019
Reference: Mol Genet Genomic Med. 2019 Dec;7(12):e1016. doi: 10.1002/mgg3.1016. Epub 2019 Oct 30.
Impact factor: 2.448
Publication type: Paper in international publication
Authors: Martin-Nalda, Andrea, Cueto-Gonzalez, Anna M, Argudo-Ramirez, Ana, Marin-Soria, Jose L, Martinez-Gallo, Monica, Colobran, Roger, Plaja, Albert, Castells, Neus, Riviere, Jacques, Tizzano, Eduardo F et al.
DOI: 10.1002/mgg3.1016

LRBA Deficiency in a Patient With a Novel Homozygous Mutation Due to Chromosome 4 Segmental Uniparental Isodisomy.

PMID: 30386343
Journal: Frontiers in Immunology
Year: 2018
Reference: Front Immunol. 2018 Oct 16;9:2397. doi: 10.3389/fimmu.2018.02397. eCollection 2018.
Impact factor: 5.511
Publication type: Paper in international publication
Authors: Soler-Palacin, Pere, Garcia-Prat, Marina, Martin-Nalda, Andrea, Franco-Jarava, Clara, Riviere, Jacques G, Plaja, Alberto, Bezdan, Daniela, Bosio, Mattia, Martinez-Gallo, Monica, Ossowski, Stephan et al.
DOI: 10.3389/fimmu.2018.02397

[Impact of the 2009 influenza A (H1N1) virus pandemic on the emergency department of a tertiary hospital].

PMID: 21420916
Journal: ANALES DE PEDIATRIA
Year: 2011
Reference: An Pediatr (Barc). 2011 Jul;75(1):13-20. doi: 10.1016/j.anpedi.2011.01.006. Epub 2011 Mar 21.
Impact factor: 0.57
Publication type: Paper in national publication
Authors: Lera Carballo, E, Worner, N T, Sancosmed Ron, M, Fabregas Martori, A, Casquero Cossio, A, Cebrian Rubio, R et al.
DOI: 10.1016/j.anpedi.2011.01.006

Thesis

Resultados de la implantación de un programa de optimización del uso de antiinfecciosos específico de pediatria en el Hospital Vall d'Hebron (PROA-NEN)

PhD student: Aurora Fernandez Polo
Director/s: Pere Soler Palacín
University: Universitat Autònoma de Barcelona
Year: 2022

Avaluació genètica amb eines de seqüenciació massiva d'una cohort de pacients amb immunodeficiència comuna variable (IDCV).

PhD student: Marina García Prat
Director/s: Pere Soler Palacín, Roger Colobran Oriol
University: Universitat Autònoma de Barcelona
Year: 2022

PROFILAXIS ANTIBIÓTICA QUIRÚRGICA EN UN PROGRAMA DE USO ADECUADO DE ANTIMICROBIANOS EN PEDIATRÍA (PROA-NEN)

PhD student: Susana Melendo Perez
Director/s: Pere Soler Palacín
University: Universitat Autònoma de Barcelona
Year: 2020

Variabilitat, efectivitat i seguretat del voriconazole en la infecció fúngica invasiva a pediatria

PhD student: Jose Maria Valle T-Figueras
Director/s: Pere Soler Palacín
University: Universitat Autònoma de Barcelona
Year: 2020

MONITORATGE DE CONCENTRACIONS PLASMÀTIQUES D’ANTIBIÒTICS EN NOUNATS DINS D’UN PROGRAMA PROA

PhD student: Natalia Ana Mendoza Palomar
Director/s: Pere Soler Palacín, Félix Castillo Salinas
University: Universitat Autònoma de Barcelona
Year: 2020

Tos ferina a Pediatria: Factors pronòstic d'evolució en el pacient hospitalitzat

PhD student: Maria Teresa Riera Bosch
Director/s: Pere Soler Palacín
University: Universitat Autònoma de Barcelona
Year: 2019

SÍNDROME METABÓLICO EN NIÑOS Y ADOLESCENTES QUE VIVEN CON EL VIH: ESTUDIO EN UNA COHORTE NACIONAL DE PACIENTES VIH PEDIÁTRICOS (CORISPE). ANÁLISIS DE FACTORES DE RIESGO RELACIONADOS CON LA RESISTENCIA INSULÍNICA EN UNA SUBCOHORTE.

PhD student: Maria Espiau Guarner
Director/s: Pere Soler Palacín, Diego Yeste Fernandez
University: Universitat Autònoma de Barcelona
Year: 2017

SENSIBILIDAD Y ESPECIFICIDAD DE LA TÉCNICA DE DETECCIÓN DE DNA DE CITOMEGALOVIRUS EN LA SANGRE SECA DE LA PRUEBA DE DETECCIÓN PRECOZ NEONATAL (PRUEBA DEL TALÓN) MEDIANTE PCR EN LOS PACIENTES AFECTOS DE CITOMEGALOVIRUS CONGÉNITO

PhD student: Isabel Vives Oñós
Director/s: Pere Soler Palacín
University: Universitat Autònoma de Barcelona
Year: 2017

Influencia de los cambios migratorios en la epidemiología de la transmisión vertical del virus de la inmunodeficiencia humana en Catalunya (período 2000-2014)

PhD student: Antoni Soriano Arandes
Director/s: Mario Marotta Baleriola
University: Universitat de Barcelona
Year: 2017

Aplicació del cribatge de l'hepatitis oculta a la cohort espanyola de pacients pediàtrics infectats pel VIH (CoRISPe)

PhD student: Marta Dapena Archilés
Director/s: Pere Soler Palacín, Antonio Carrascosa Lezcano
University: Universitat de Barcelona
Year: 2016

Hipertactacidemia en el hijo de madre VIH expuesto a antirretrovirales. Estudio de cohortes, abierto y prospectivo (2004-2007)

PhD student: Pere Soler Palacín
Director/s: Concepción Figueras Nadal
University: Universitat Autònoma de Barcelona
Year: 2010

Estudio clínico-epidemiológico de la neumonía aguda comunitaria no complicada en el niño: papel etiológico y características diferenciales de Mycoplasma pneumoniae

PhD student: Concepción Figueras Nadal
Director/s: Alfredo Gallart Català
University: Universitat Autònoma de Barcelona
Year: 2010

Hiperlactacidemia en el fill de mare VIH i exposat a antiretrovirals Estudi de cohorts, obert i prospectiu

PhD student: Pere Soler Palacín
Director/s: Concepción Figueras Nadal
University: Universitat Autònoma de Barcelona
Year: 2007

Estudi clínic epidemiològic de la pneumònia aguda comunitària no complicad en el nen: Paper etiològic i característiques diferencials de Mycoplasma pneumoniae

PhD student: Concepción Figueras Nadal
Director/s: Josep Maria Gallart Capdevila
University: Universitat Autònoma de Barcelona
Year: 2006

Blog

News

The PhD student of the research group Infection in the immunocompromised pediatric patient has received one of the Junior Talent Awards given by the organization.

The donation allows to advance in the research of the mechanisms of primary immunodeficiencies and to evaluate the pathogenicity of mutations in patients.

The article on the mortality rate of young people with HIV due to perinatal transmission after transitioning to adult health care in Spain received the PIDJ award.

Job offers

Psychologist - The research group of immunodepressed paediatric patients
Start date:
20/05/2022
End date:
04/05/2022
Document: Download
Study Nurse-Infection in the immunocompromised child Research Group.
Start date:
03/02/2022
End date:
04/03/2022
Document: Download
Data manager-Infection in the immunocompromised child Research Group.
Start date:
02/02/2022
End date:
16/02/2022
Document: Download